LYNN PATEL: Open Payments
NPI 1952649642 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 44 payments from 23 companies in 2025. Trend: 2023 $124 · 2024 $0 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| Sequel Med Tech, LLC | 4 | $82 |
| Antares Pharma, Inc. | 3 | $71 |
| Novo Nordisk Inc | 3 | $57 |
| Lilly USA, LLC | 3 | $56 |
| Tandem Diabetes Care, Inc. | 3 | $54 |
| Dexcom, Inc. | 3 | $51 |
| Abbott Laboratories | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
Products named: Kerendia, TWIIST, XYOSTED, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, GVOKE HYPOPEN.
Industry payments across FL — which companies pay providers there.
